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ABSTRACT: α-Mannoside β-1,6-N-acetylglucosaminyltransferase V
(MGAT5) is a mammalian glycosyltransferase involved in complex
N-glycan formation, which strongly drives cancer when overex-
pressed. Despite intense interest, the catalytic mechanism of MGAT5
is not known in detail, precluding therapeutic exploitation. We solved
structures of MGAT5 complexed to glycosyl donor and acceptor
ligands, revealing an unforeseen role for donor-induced loop
rearrangements in controlling acceptor substrate engagement. QM/
MM metadynamics simulations of MGAT5 catalysis highlight the key
assisting role of Glu297 and reveal considerable conformational
distortions imposed upon the glycosyl donor during transfer. Detailed
mechanistic characterization of MGAT5 will aid inhibitor develop-
ment to correct cancer-associated N-glycosylation.
KEYWORDS: enzymes, N-glycosylation, carbohydrates, glycosyltransferases, quantum mechanics/molecular mechanics
P rotein N-glycosylationthe attachment of a glycan to thenitrogen of an Asn side chainis one of the most prevalent
eukaryotic post-translational modifications,1 estimated to
decorate over half of all proteins.2 N-Glycosylation of proteins
serves diverse functions, including regulating protein folding3
and stability.4 Cell surface N-glycans modulate the properties of
their underlying proteins and also engage directly with the
extracellular matrix.5 The formation and maturation of N-
glycans is nontemplated, leading to the production of diverse
protein glycoforms that reflect the function and physiological
state of the cell.6 Accordingly, changes to cellular N-
glycosylation patterns are major features of malignant trans-
formation, which can drive further oncogenic behavior in
transformed cells.7
α-Mannoside β-1,6-N-acetylglucosaminyltransferase V
(MGAT5, also GnT-V) is a mammalian medial-Golgi inverting
glycosyltransferase, which transfers N-acetylglucosamine
(GlcNAc) from a UDP-GlcNAc glycosyl donor on to the core
α-1,6 mannose (Man) of an N-glycan acceptor (Figure 1). The
resulting branched GlcNAc-β-1,6-Man linkage is a precursor for
the formation of complex tri- and tetra-antennary N-glycans,
which are elaborated in the trans-Golgi by the addition of Gal-β-
1,4-GlcNAc (LacNAc) disaccharides and sialic acids.8
MGAT5 overactivity drives cancer aggression via increased
LacNAc prevalence. LacNAcs on N-glycosylated membrane
proteins bind galectins, forming cell-surface “lattices” that
protect against endocytic turnover.9 Pro-oncogenic growth
factor receptors, which are typically heavily N-glycosylated, thus
show reduced turnover and potentiated signaling uponMGAT5
induction.10,11 Galectin binding can also activate angiogenic
receptors, providing a noncanonical route toward tumor
neovascularization.12 Notably, the β-1,6 linked products of
MGAT5 activity are preferentially elaborated by poly-LacNAc
repeats (Figure 1),13 which bind galectins with higher avidity
and affinity.
Reducing MGAT5 activity inhibits tumor growth. Viral
oncogene-induced tumor formation is severely suppressed in
Mgat5 negative mice.14 Similarly, Mgat5 knockdown in murine
mammary adenocarcinoma cells reduces their tumorigenicity in
vivo.15 To date, very few effective small-molecule inhibitors of
MGAT5 have been developed,16−18 owing to a lack of
understanding of MGAT5 enzyme−substrate interactions and
catalytic mechanisms. In seminal work, Nagae et al. recently
reported the crystal structure of an inactive MGAT5 mutant
complexed to an acceptor glycan analogue, revealing details of
the enzyme fold and its acceptor binding interactions.19
However, the molecular basis for MGAT5 engagement with
its donor substrate UDP-GlcNAc remains unknown, funda-
mentally limiting our understanding of the interactions that lead
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to glycosyl transfer. Here, we report novel structures of MGAT5
in complex with glycosyl donor and acceptor ligands, and use
these structures to uncover the enzyme mechanism by means of
quantum mechanics/molecular mechanics (QM/MM) simu-
lations, thereby building a molecular overview of the MGAT5
catalytic cycle.
MGAT5 is a type-II-transmembrane enzyme, consisting of a
cytoplasmic N-terminal domain, single pass transmembrane
helix, linker sequence, and globular catalytic domain. Based on
biochemical studies of rat Mgat5,20 we designed a truncated
human MGAT5 expression construct spanning Ser214−Ile741,
omitting the transmembrane helix and the noncatalytic N-
terminal domains of the enzyme. A second construct addition-
ally incorporating a Lys329−Ile345−>(Gly)4 loop truncation
was also designed, following observations that the Lys329−
Ile345 loop is dispensable for MGAT5 activity.19 Both MGAT5
constructs expressed well in lepidopteran cells, and both showed
robust in vitro activity in assays using the synthetic biantennary
pentasaccharide M592 as a glycosyl acceptor. Kinetic parame-
ters for transfer were broadly similar between the two constructs,
although the Lys329−Ile345 truncated construct showed kcat
values consistently ∼3× higher than the full Lys329−Ile345
loop construct, and the full Lys329−Ile345 loop construct
showed a∼2.3×more potentKM forM592 (Table 1; Figure S1).
Compared with previous reports,10,19,20 we also noted a higher
acceptor substrate KM in our assays, probably because of the
minimal structure of M592 compared to previously used
acceptors.
Our MGAT5 constructs crystallized readily in the P212121
(full Lys329−Ile345 loop) and P1 (Lys329−Ile345 truncated)
space groups (Table S1; Figure S2a), with similar folds to each
other and to previously reported structures (Figure S3). Both
crystal forms contained 2 MGAT5 molecules in the asymmetric
unit (ASU), albeit with differing relative orientations of the
protein monomers, suggesting no functional oligomer in
solution (Figure S2b). P212121 crystals typically diffracted
poorly (below 3.5 Å resolution), although one highly anisotropic
data set processed to 2.20 Å using STARANISO (Figure S4).21
In contrast, P1 crystals consistently diffracted to better than 2 Å
resolution, and were also highly amenable to ligand derivatiza-
tion. Soaking P1 crystals with M592 (acceptor substrate) or
UDP (donor product) produced binary cocrystal complexes
Figure 1. N-Glycan processing reaction catalyzed by MGAT5. β-1,6 linked products of MGAT5 activity are highlighted in red. The M592
pentasaccharide structure is highlighted in black.
Table 1. Kinetic Parameters for the Full Lys329−Ile345 Loop and Lys329−Ile345 Truncated MGAT5 Catalyzed Reactionsa
donor (UDP-GlcNAc) acceptor (M592)
KM/mM kcat/s
−1 KM/mM kcat/s
−1
full Lys329−Ile345 loop 1.08 ± 0.21 0.06 ± 0.004 1.81 ± 0.07 0.35 ± 0.01
Lys329−Ile345 truncated 0.84 ± 0.30 0.16 ± 0.02 4.18 ± 1.19 1.08 ± 0.19
aError ranges represent standard errors of the means. N = 2.
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with clearly interpretable electron density in the MGAT5
acceptor or donor subsites, respectively.
Protein interactions in our MGAT5-M592 binary complex
were mainly directed toward the M592 α-1,6-branch GlcNAc,
which anchors the glycan within the acceptor subsite. This 1,6-
branch GlcNAc is added to nascent N-glycans by MGAT2/
GnT-II, highlighting the dependence of MGAT5 upon earlier
enzymes in the N-glycan processing pathway. We also observed
direct H-bonds to M592 from Asp378, Ser379, and Lys554, a
CH-π interaction from Trp401, and H-bonds from symmetry
related Glu258 and Glu263 side chains (Figure 2). Inverting
glycosyltransferases such as MGAT5 are expected to operate via
a one-step SN2 type mechanism, with nucleophilic attack by the
acceptor onto the glycosyl donor assisted by a catalytic base
residue from the enzyme.22 Surprisingly, we observed no
interaction between the acceptor nucleophile (the M592 α-1,6
mannose O6) and the putative MGAT5 catalytic base Glu297,
which instead coordinated to the nearby Ser379 side chain and
GlcNAc acetamide. Thus, our MGAT5-M592 complex and the
pseudoacceptor complex previously reported by Nagae19
(Figure S5) likely correspond to catalytically inert MGAT5
configurations.
No MGAT5 complexes with donor subsite ligands have been
reported to date, and the effects of donor binding on MGAT5
activity are poorly understood. Our MGAT5-UDP binary
complex revealed that UDP binding induces extensive
reordering of the MGAT5 Lys279−Gly293 loop (Figure 3),
which is otherwise highly mobile in structures lacking donor
subsite occupation (our unliganded and M592 structures and
those from Nagae19). Lys279−Gly293 loop ordering was
primarily driven by H-bonding between the UDP pyrophos-
phate and the backbone amides of Leu295 and Gly296, with H-
bonds also observed from UDP to Lys454, Tyr452, Glu526,
Leu497, and Ala523, as well as a molecule of ethylene glycol
Figure 2. MGAT5 (gray) binary complex with the M592
pentasaccharide (green). Symmetry related residues in pink. No
interaction is observed between the MGAT5 catalytic base (Glu297)
and the acceptor nucleophilic atom (O6). Electron density is REFMAC
σA-weighted 2mFo−DFc, contoured to 1σ (0.29 e
−
·Å−3).
Figure 3. MGAT5 (gray) binary complex with UDP (pink). The
Lys279−Gly293 loop (blue) is ordered upon occupation of the donor
subsite. Electron density is REFMAC σA-weighted 2mFo−DFc,
contoured to 1σ (0.20 e−·Å−3). E.G.: ethylene glycol.
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Figure 4. MGAT5 (gray) ternary complex with UDP (pink) and M592 (green). (a) Occupation of both donor and acceptor subsites enables the
MGAT5 catalytic base (Glu297) to coordinate the acceptor nucleophile atom (O6) of M592. (b) Displacement of M592 by the ordered Lys279−
Gly293 loop in the UDP+M592 ternary complex, compared with its binary complex (cyan); see also Figure S7a. Electron density is REFMAC σA-
weighted 2mFo−DFc, contoured to 1σ (0.20 e−·Å−3).
Figure 5.Atomic rearrangement along the glycosyl transfer reaction coordinate (MC′: pre-Michaelis complex;MC: Michaelis complex;TS: transition
state; P: product complex). The transferred GlcNAc undergoes electrophilic migration from UDP-GlcNAc to the acceptor α-mannose O6, with clear
oxocarbenium-like character at TS. Red dashes: bonds broken/formed. Black dashes: relevant H-bonds.
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from the crystallization solution (one ASU only). No metal
coordination sites were present in our UDP binary complex,
consistent with the metal-independent nature of MGAT5
activity.
The extensive structural effects of UDP binding upon
MGAT5 prompted us to investigate possible interactions
between the enzyme donor and acceptor subsites. Attempts to
generate a stable ternary substrate complex analogue using
UDP-2FGlc (a nonhydrolyzable UDP-GlcNAc mimic) resulted
in binding modes considered to be catalytically implausible
(Figure S6). However, a ternaryMGAT5+M592+UDP complex
could be readily obtained by soaking MGAT5 crystals with both
molecules (Figure 4a). UDP interactions to MGAT5 in this
ternary complex were essentially identical to its binary complex
and also induced Lys279−Gly293 loop ordering. In contrast,
M592 was substantially displaced from its binary complex
position by the now structured Lys279−Gly293 loop (Figure
4b; Figure S7a), enabling a water mediated H-bonding network
to form between UDP, Glu297, and the acceptor α-mannose.
Crucially, this H-bonding network involves a direct interaction
between Glu297 and the α-mannose O6, creating a catalytically
poised active site in which acceptor nucleophile deprotonation is
possible. Although few direct interactions were observed
between M592 and the Lys279−Gly293 loop (a CH-π bond
between Phe283 and the central M592 mannose; Figure S7b), it
appears that Lys279−Gly293 loop formation in itself sterically
constrains the MGAT5 acceptor subsite, ensuring that acceptor
glycans can only bind in catalytically productive configurations.
Our data thus suggest a sequential bi-bi MGAT5 reaction
profile,23,24 in which UDP-GlcNAc binding likely precedes
Lys279−Gly293 loop ordering and acceptor binding during
Michaelis complex formation. We note that our studies with
M592 do not preclude further interactions that may occur for
bona f ide protein N-glycan substrates, such as the contact
between the chitobiose core and the MGAT5 protein surface
previously postulated by Nagae.19
Given our new structural insights, notably the role of Lys279−
Gly293 loop induced acceptor repositioning, we next sought to
model the MGAT5 reaction using molecular dynamics (MD)
and QM/MM methods, which can provide a comprehensive
description of enzyme mechanism. We reconstructed a
postulated MGAT5 Michaelis complex from the UDP+M592
ternary complex, via manual addition of a GlcNAc bound to the
UDP β-phosphate, guided by the positions of existing active site
waters (Figure S8). MD simulations25 (120 ns) confirmed that
this complex was stable, reaching a maximum Cα root-mean-
square-displacement of ∼1.5 Å after 20 ns (Figure S9). M592
appeared relatively mobile in the acceptor subsite, adopting two
main substrate poses, with the major pose corresponding to a
state well-poised for nucleophilic attack (Figure S10).
QM/MM metadynamics simulations were initiated from a
representative snapshot of the MD simulation in its major
pose.26,27 The QM region was described with density functional
theory (DFT), using the Perdew−Burke−Ernzerhof (PBE)
functional, whereas the MM region was described with the
Amber force field (see Supporting Information). The reaction
was driven from reactants to products using a single collective
variable (CV), which combines the main bonds formed and
cleaved during the reaction. The CV was defined as the
difference of C1−OUDP (the GlcNAc-phosphate bond) and
C1−O6 (the GlcNAc bond to the acceptor α-mannose O6)
distances. This chosen CV does not self-select any specific
reaction pathway, and crucially, does not dictate whether
Glu297 is part of the reaction pathway.
Analysis of the simulated reaction free energy profile provides
an atomistic picture of theMGAT5 catalytic mechanism (Figure
5; Supporting Video). A pre-Michaelis complex (MC′) in the
region of the reactants state is formed, in whichGlu297 is not yet
coordinated to M592.MC′ is separated from the true Michaelis
complex (MC) by a small energy barrier (∼2.5 kcal.mol−1),
corresponding to subtle repositioning movements that enable
H-bonding between Glu297 and O6Man−H, a prerequisite for
proton transfer later in the reaction. The enzyme atMC is well-
poised for catalysis, with the acceptor α-mannosyl O6 lying 3.36
Å from the GlcNAc anomeric carbon (C1), almost perfectly
oriented for in-line nucleophilic attack (O6Man···C1−OUDP ≈
170°) (Table 2).
Glycosyl transfer proceeds toward the transition state (TS)
via elongation of the bond between the UDP and GlcNAc
moieties (C1−OUDP), with a concurrent approach of the α-
mannosyl acceptor. At TS, GlcNAc lies tightly sandwiched
between the α-mannosyl acceptor and UDP β-phosphate, and it
exhibits clear oxocarbenium ion character, exemplified by a
distorted 4H3 ring conformation (vide infra), reduced C1−O5
bond length, and increased positive charge at C1 (Figure 5;
Table 2). We also observed partially broken/formed C1−OUDP
and C1−O6Man bonds, respectively; an elongated O6Man−H
bond; and a shortened H-bonding distance between the
acceptor O6 and the Glu297 sidechain (O6Man−H···OGlu297).
The reaction resolves toward the product state (P) as the
O6Man−H proton transfers onto Glu297, confirming its role as
catalytic base, while GlcNAc moves toward O6Man, forming the
new β-1,6 glycosidic bond. Our computed reaction free-energy
profile exhibits a single transition state, indicative of a concerted
mechanism, with a free energy barrier (15 kcal·mol−1) consistent
with that estimated from the experimental rate constant (∼17
kcal·mol−1).
Conformational ring distortions are commonly employed by
glycoside hydrolases (the enzymes that cleave glycosidic bonds)
as a strategy to facilitate nucleophilic displacement.28 However,
despite some mechanistic similarities, ring distortions have to
date remained unreported in inverting glycosyltransferases. Our
QM/MM simulation revealed a distinct conformational
itinerary for the GlcNAc ring during its transfer from donor to
Table 2. Relevant Parameters Involving the Donor and
Acceptor at Each Characteristic Point along the Reaction
Coordinatea
structural parameter MC TS P
Distance (Å)
C1GlcNAc-OUDP 1.52 ± 0.06 2.45 ± 0.07 3.48 ± 0.06
C1GlcNAc-O6Man 3.36 ± 0.09 2.69 ± 0.08 1.50 ± 0.05
O6Man-H6Man 1.02 ± 0.04 1.04 ± 0.03 1.79 ± 0.25
H6Man-OGlu297 1.69 ± 0.16 1.65 ± 0.24 1.02 ± 0.03
C1GlcNAc-O5GlcNAc 1.38 ± 0.03 1.28 ± 0.03 1.39 ± 0.04
Angle (deg)
O6Man···C1−OUDP 169.42 ± 5.51 168.42 ± 6.27 171.65 ± 4.11
Chargeb
C1GlcNAc +0.07 ± 0.01 +0.15 ± 0.01 +0.06 ± 0.01
aSubscript labels refer to the molecule to which the atom belongs to
at MC. bRestrained electrostatic potential atomic partial charge
(RESP), in electron units.
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acceptor. At MC, GlcNAc maintains a ground state 4C1 ring
conformation, as its axially oriented UDP leaving group is
already well-poised for attack. As the GlcNAc anomeric center
proceeds in its migration fromUDP toM592 and the C1−OUDP
bond breaks, the sugar ring changes to a distorted [4H3]
‡
conformation at TS, characteristic of an oxocarbenium ion-like
species. Finally, formation of the new glycosidic bond with
M592 is accompanied by H-bonding between the GlcNAc N-
acetyl moiety and the tightly abutting α-mannose O4 and UDP
β-phosphate groups, which enforce a distorted 1,4B ring
conformation even after glycosyl transfer (P)a situation
reminiscent of the product distortion sometimes observed for
inverting glycoside hydrolases.29,30 Relaxation of GlcNAc back
to a ground state 4C1 conformation likely accompanies diffusion
of the product glycan out of the MGAT5 active site.
Overall, we have expanded considerably upon existing
structural knowledge of MGAT5, by providing the first
molecular characterization of MGAT5 donor subsite inter-
actions, which revealed large rearrangements of the Lys279−
Gly293 loop that are fundamental to the catalytic cycle. QM/
MM simulations based upon our structural data provide a
detailed description of MGAT5 catalyzed transfer, confirming
the essential assisting role of Glu297 in the reaction mechanism
and capturing the conformational itinerary undertaken by
GlcNAc throughout its migration from donor to acceptor.
Given its prominent role in cancer progression, there remains
intense interest in the development of novel inhibitors to control
pathological MGAT5 overactivity. Our work provides a
comprehensive molecular overview of MGAT5 catalysis that
will guide such inhibitor development efforts. Notably, strategies
based upon conformational mimicry have successfully delivered
inhibitors against many classes of glycoside hydrolases.31,32 We
suggest that pharmacological targeting of the MGAT5 donor
subsite, using inhibitors inspired by conformational analysis,
may also prove to be effective for the development of
compounds to control the activity of this glycosyltransferase.
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